Combinatorial Immunotherapy Approaches for Patients with Advanced Solid Tumors
Sponsor: UltivueIn this exciting new webinar, sponsored by Ultivue, we will explore the intratumoral administration of autologous, non-manipulated myeloid dendritic cells in combination with immune checkpoint inhibitors in patients with advanced solid tumors and in combination with the oncolytic virus talimogene laherparepvec (Imlygic®) in patients with advanced melanoma in phase I clinical trials.
Promising COVID-19 Immunotherapy Targets CCR5
Sponsor: Bio-RadIn this Clinical OMICs webinar, sponsored by Bio-Rad, IncellDx presents an overview of CCR5 antagonists and the ddPCR data that enabled validation of their hypothesis to move 4 CCR5 inhibitors into trials for treatment of COVID-19.
Comprehensive Genomic and Immune Profiling to Support Drug Development
Sponsor: IlluminaIn this Clinical OMICs webinar, sponsored by Illumina, we will discover how combining molecular and immune profiling's power to drive molecular-based testing is improving stratification methods and patient outcomes. Additionally, our expert panelist will showcase the impact of a scalable, comprehensive assay, and infrastructure in the context of drug development.
Optical Mapping in Rare Genetic Disease Diagnosis
Sponsor: Bionano Genomics
Mainstreaming Precision Oncology
Sponsored content brought to you by
What if every patient’s oncologist or lab testing personnel had access to an online digital encyclopedia of cancer mutations,...
LeukoVantage: A Quest/QIAGEN Partnership Providing Clinical Insights Into Myeloid Malignancies
Sponsor: QiagenIn this webinar, we will describe Quest’s LeukoVantage assay, an NGS test designed specifically for detecting clinically relevant variants in myeloid malignancies, and its partnership with N-of-One, a QIAGEN company, for expert interpretation.
Cancer Gene Variant Detection Using a Pre-Optimized Sample to Report Workflow
Sponsor: Qiagen
REGISTER NOW
Broadcast Date: September 12, 2019
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
BRCA1/BRCA2 genes represent the best examples for our current understanding of...
Cell and Gene Therapy Clinical Trials
Sponsor: ICONThe promise of cell and gene therapies to solve some of our most challenging conditions, from rare diseases to cancers, has led this field to remain on the forefront of innovation. Advances in innovative technologies coupled with deeper scientific knowledge in cellular and molecular biology spurred a new era of growth in these advanced therapies.
In-Cell Protein Footprinting: A New Tool for Proteome-Wide Structural Biology
Sponsor: ThermoFisher Scientific
VIEW NOW
Broadcast Date: June 26, 2019
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
Protein structure must be studied in its native cellular environment, otherwise,...
The Next Era in Pathway Proteomics: Turnkey Targeted Quantitation Workflows
Sponsor: ThermoFisher Scientific
REGISTER NOW
Broadcast Date: October 1, 2019
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
Accurate monitoring of cell signaling pathway proteins, particularly tyrosine phosphorylation (pTyr)...